CVS HEALTH Corp (CVS)
Retail-Drug Stores and Proprietary Stores · Retail-Drug Stores and Proprietary Stores · NYSE
$93.65
-1.33%
Investingg Score
41.3 / 100
Sell
Business overview
- Gross margin of 45%
- Operating margin of 1.2%
These margins show that while the company retains a solid gross profit profile on its sales, very thin operating margins highlight heavy operational expenses that strain overall profitability.
Financial health
- Free cash flow margin of 1.9%
- Balance sheet pillar score of 33
These metrics indicate modest cash generation relative to revenue alongside a relatively weak balance sheet assessment.
- Gross Margin
- 45.0%
- Operating Margin
- 1.2%
- Current Ratio
- 0.8x
- Debt / Equity
- Data unavailable
- Free Cash Flow (TTM)
- $7.8B
- Interest Coverage
- 1x
Valuation
- P/E ratio of 40.1
- Forward P/E of 13.16
- P/S ratio of 0.29
- Free cash flow yield of 6.6%
While trailing earnings look expensive, the lower forward P/E and attractive free cash flow yield suggest potential value if future estimates materialize.
- P/E (TTM)
- 40.1x
- Forward P/E
- 13.2x
- Price / Sales
- 0.3x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 6.6%
Key risks
- Operating margin of 1.2% indicates very thin operational buffer against cost increases.
- Year-over-year EPS growth of -62% points to severe earnings deterioration.
- RSI of 24.37 signals oversold technical conditions with heightened short-term price uncertainty.
Market cap $119.0B · data as of 2026-08-19
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze CVS with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.